Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(20%)
Results Posted
38%(3 trials)

Phase Distribution

Ph not_applicable
9
90%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(8)

Detailed Status

Completed8
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (10.0%)
N/A9 (90.0%)

Trials by Status

active_not_recruiting220%
completed880%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10